Press Releases :: Aethlon Medical, Inc. (AEMD)

Aethlon Medical is closely monitoring the Bird Flu situation and stands ready to work alongside hospitals, health agencies and the FDA if existing therapies prove inadequate.

Year

Category

May 14, 2025

Aethlon Medical Announces Publication of Preclinical Data Showing Ability of the Hemopurifier® to Remove Platelet-Derived Extracellular Vesicles from Plasma

Mar 10, 2025

Aethlon Medical Publishes Preclinical Data on the Hemopurifier® in Transplant Immunology Journal

Feb 13, 2025

Aethlon Medical to Present at the Emerging Growth Conference on February 19, 2025

Feb 12, 2025

Aethlon Medical Announces Financial Results for the Fiscal Third Quarter Ended December 31, 2024 and Provides Corporate Update

Feb 5, 2025

Aethlon Medical to Release Fiscal Third Quarter Financial Results and Host Conference Call on February 12, 2025

Jan 29, 2025

Aethlon Medical Treats First Patient in Australian Hemopurifier® Cancer Trial

Dec 20, 2024

Aethlon Medical Provides Update on the Ability of Its Hemopurifier® to Capture H5N1 Bird Flu

Nov 13, 2024

Aethlon Medical Announces Financial Results for the Fiscal Second Quarter Ended September 30, 2024 and Provides Corporate Update

Nov 11, 2024

Aethlon Medical Reaches Key Milestone with Enrollment of the First Patient in (FPI) Its Hemopurifier® Cancer Trial in Australia

Nov 6, 2024

Aethlon Medical to Release Fiscal Second Quarter Financial Results and Host Conference Call on November 13, 2024

rss_feed News RSS